Toward Holistic Psychiatry: Saffron, SSRIs, and the Future of Natural Mental Health Interventions

Dear Editor, We are writing in response to the article entitled “Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials” by Shafiee et al, published in Nutrition Reviews.1 The authors present an important synthesis of current evidence comparing the effectiveness of saffron and SSRIs in the treatment of depression and anxiety. This review arrives at a critical moment, as global mental health systems continue to search for more effective, accessible, and tolerable interventions. The study’s findings demonstrate that saffron (Crocus sativus) shows comparable efficacy to SSRIs in reducing symptoms of both depression and anxiety, with the added benefit of significantly fewer adverse events. By aggregating data from 12 randomized controlled trials, this meta-analysis offers one of the most comprehensive evaluations to date of saffron’s therapeutic potential. These results are particularly compelling given the well-documented side effects of SSRIs, which often lead to treatment discontinuation and reduced quality of life for patients.